Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.97 USD | +2.54% | +1.91% | +125.42% |
02/06 | Transcript : Cullinan Therapeutics, Inc. - Special Call | |
01/06 | Cullinan Therapeutics, Inc. Announces Positive Initial Data from Pivotal Phase 2b Rezil1 Study of Zipalertinib | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.32B | - | - | - | - | - | |
56.95B | - | |||||
40.26B | ||||||
39.32B | ||||||
28.37B | ||||||
26.45B |